Menu
Fechar
hrs4r
 I want to donate

The research group for descriptive epidemiology, genetics, and prevention of cancer is a multidisciplinary group that includes epidemiologists, statisticians, oncologists, radiotherapists, a physiotherapist, a dermatologist; a biologist, a nurse, and medical documentalists, biologist. The main focus of the group is cancer epidemiology (descriptive and analytical), cancer prevention, and genetics.

Main lines of research

Descriptive and analytical epidemiology of cancer.

Strategic objectives
  1. Descriptive and analytical epidemiology of cancer
  • Registering cancer based on population for the province of Girona (with national and international collaborations).
    • Incidence and populational prevalence of cancer, projections of the incidence of cancer
    • Populational survival of cancer (international collaborations: EUROCARE and CONCORD studies).
  • Study of genetic and molecular factors in the prognosis of breast cancer and haematological tumours.
  • Study of genetic and environmental risk factors in breast cancer and chronic lymphocytic leukaemia.
  1. Cancer prevention
  • Evaluation of the organized breast cancer screening program
  • Benefits and adverse effects of breast cancer detection: Method to improve the measurement of early detection results.
  • Evaluation of the interval rate of cancer and its determining factors in the early detection program of breast cancer in the Girona health region.
  • Evaluation of the timely detection program for cervical cancer.
  • Determination of the sensitivity and specificity of cervical cytology.
  • Evaluation of the effectiveness of vaccination against the human papilloma virus.
  1. Genetics (The genetic epidemiology of cancer)
  • Evaluation of the risk of developing cancer.
  • Study of genetic risk factors for cancer.
  • Genetic susceptibility to cancer.
Publications
Daltveit DS, Morgan E, Colombet M, Steliarova-Foucher E, Bendahhou K, Marcos-Gragera R, Rongshou Z, Smith A, Wei H, Soerjomataram I

Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022.

Leukemia, 2025, 39, 412-419 dx.doi.org/10.1038/s41375-024-02452-y
Trama, A, Bernasconi, A, Cañete, A, Carulla, M, Daubisse-Marliac, L, Rossi, S, De Angelis, R, Sanvisens, A, Katalinic, A, Paapsi, K, Went, P, Mousavi, M, Blum, M, Eberle, A, Lamy, S, Capocaccia, R, Didonè, F, Botta, L

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study

EUROPEAN JOURNAL OF CANCER, 2025, 214, 115147-115147 dx.doi.org/10.1016/j.ejca.2024.115147
Mafra A, Laversanne M, Marcos-Gragera R, Chaves HVS, Mcshane C, Bray F, Znaor A

The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025 dx.doi.org/10.1093/jnci/djae321
Filho AM, Znaor A, Sunguc C, Zahwe M, Marcos-Gragera R, Figueroa JD, Bray F

Cancers of the brain and central nervous system: global patterns and trends in incidence.

JOURNAL OF NEURO-ONCOLOGY, 2025 dx.doi.org/10.1007/s11060-025-04944-y
Di Carlo V, Eberle A, Stiller C, Bennett D, Katalinic A, Marcos-Gragera R, Girardi F, Larønningen S, Schultz A, Lima CA, Coleman MP, Allemani C

Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries.

EUROPEAN JOURNAL OF CANCER, 2025, 217, 115213-115213 dx.doi.org/10.1016/j.ejca.2024.115213
Rubio-Casadevall, J, Trallero, J, Calvo, C, Puigdemont, M, Carulla, M, Sanvisens, A, Ameijide, A, Vidal, A, Pla, C, Marruecos, J, Marcos-Gragera, R, Galceran, J

A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018

CLINICAL & TRANSLATIONAL ONCOLOGY, 2025 dx.doi.org/10.1007/s12094-025-03855-8
Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A

Corrigendum to "Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results" [Eur J Cancer 213 (2024):115079].

EUROPEAN JOURNAL OF CANCER, 2025, 218, 115295-115295 dx.doi.org/10.1016/j.ejca.2025.115295
Sanvisens, A, Bueno, C, Calvete, O, Solé, F, Marcos-Gragera, R, Solans, M

Prenatal and Perinatal Factors Associated with Infant Acute Lymphoblastic Leukaemia: A Scoping Review

Cancers, 2025, 17 dx.doi.org/10.3390/cancers17030370
Vener, C, Lillini, R, De Angelis, R, Bonfarnuzzo, S, Poirel, HA, Trama, A, Visser, O, Troussard, X, Marcos-Gragera, R, Maynadié, M, Demuru, E, Di Benedetto, C, Johannesen, TB, Solans, M, Paapsi, K, Guevara, M, Mousavi, SM, Blum, M, Von Moos, R, Bennett, D, Ragusa, R, Guilloteau, A, Mcshane, CM, Rossi, S, Sant, M

Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study

EUROPEAN JOURNAL OF CANCER, 2025, 220 dx.doi.org/10.1016/j.ejca.2025.115231
Mostaghim A, Minkove S, Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S, Dettorre GM, Fox L, Tondini C, Brunet J, Carmona-García M, Lambertini M, Bower M, Newsom-Davis T, Sharkey R, Pria AD, Rossi M, Plaja A, Salazar R, Sureda A, Prat A, Michalarea V, Van Hemelrijck M, Sita-Lumsden A, Bertuzzi A, Rimassa L, Rossi S, Rizzo G, Pedrazzoli P, Lee AJ, Murphy C, Belessiotis K, Diamantis N, Mukherjee U, Pommeret F, Stoclin A, Martinez-Vila C, Bruna R, Gaidano G, D'Avanzo F, Gennari A, Athale J, Eichacker P, Pinato DJ, Torabi-Parizi P, Cortellini A

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 139, 13-20 dx.doi.org/10.1016/j.ijid.2023.11.021
Competitive projects
Descriptive epidemiology, genetics and cancer prevention

European Linkage of Initiative from Science to Action in Health

Codi oficial: 101128640 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: EUROPEAN COMISSION
Transfer
Guies clíniques

- Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study.

- A Poveda; V Martinez; C Serrano; I Sevilla; M J Lecumberri; RD de Beveridge; A Estival; D Vicente; J Rubió; J Martin-Broto J. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical Translational Oncology. Dec;18(12):1221-1228

- Gavin A,Rous B, Marcos-Gragera R, Middleton R, Steliarova-Foucher E, Maynadie M, Zanetti R, Visser O; European Network of Cancer Registries. “Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses”. European Journal of Cancer. 2015 Jun;51(9):1109-22. doi: 10.1016/j.ejca.2014.02.008

- Luque R,Benavides M,Del Barco S,Egaña L,García J,Martínez M,Pérez P,Pineda E,Sepúlveda JM,Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021. 23(5):p. 940-947. IF:3,405. (Q3).

Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

 menu